title: Bladder cancer in 2014: From the genomic frontier to immunotherapeutics.
authors.affiliation: Department of Urology, David Geffen School of Medicine, University of California Los Angeles, 300 Stein Plaza, 3rd Floor, Los Angeles, CA 90095, USA.
authors.forename: Andrew T
authors.initials: AT
authors.lastname: Lenis
authors.affiliation: Department of Urology, David Geffen School of Medicine, University of California Los Angeles, 300 Stein Plaza, 3rd Floor, Los Angeles, CA 90095, USA.
authors.forename: Karim
authors.initials: K
authors.lastname: Chamie
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000235:genetics / Q000628:therapy*; D042002:Chromatin Assembly and Disassembly; D015653:Cystectomy / Q000379:methods; D044127:Epigenesis, Genetic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D056245:Mi-2 Nucleosome Remodeling and Deacetylase Complex; D015398:Signal Transduction; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000628:therapy*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D056245:Mi-2 Nucleosome Remodeling and Deacetylase Complex